Public Sector Plan Sponsors Applaud the Enactment of the Inflation Act of 2022
The enactment of the Inflation Reduction Act of 2022 is an historic step towards lowering prescription drug costs for America’s public sector employees, retirees and their families.
“For over a decade, the Public Sector HealthCare Roundtable has advocated on a bipartisan basis for a range of federal policy solutions to address the rising cost of prescription drugs in the U.S. In recent years, addressing skyrocketing prescription drug prices has been the Roundtable’s top federal legislative priority,” said Tom Lussier, Administrator of the Roundtable. “We applaud the Congress and President Biden for their leadership in passing and signing this historic bill that marks a major victory for the Roundtable and its members.”
Click here for full Roundtable Press Release